Alzecure: Receives Approval to Start ACD856 Phase I “MAD” Study
We give a brief comment on today's news that Alzecure has recieved approval to start the "MAD"-part of its phase 1 study for ACD856.
Sign up for free to continue
Already a member?
Disclosures and disclaimers
Premium Plan required to unlock